Prostate cancer: A current perspective

Epidemiologic Reviews

Volumn 13, Issue 1, 1991, Pages 200-227

  Nomura, Abraham M Y ^a,b   Kolonel, Laurence N ^b  

^a KUAKINI MEDICAL CENTER   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CAROTENOID; FAT; RETINOL; SEX HORMONE;

AGE; ANTHROPOMETRY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; DIET; DISEASE COURSE; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; LIVER CIRRHOSIS; OCCUPATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RACE DIFFERENCE; REVIEW; SEXUAL BEHAVIOR; VASECTOMY; VIRUS;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMPARATIVE STUDY; HUMAN; MALE; MIDDLE AGE; OCCUPATIONAL DISEASES; PROSTATIC NEOPLASMS; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; WORLD HEALTH;

EID: 0026376792     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a036069     Document Type: Article

References (212)

1. Ries LA, Hankey BF, Edwards BK, eds. Cancer statistics review 1973-1987. Washington, DC: US GPO, 1990. (NIH publication no. 90-2789).
2. Boring CC, Squires TS, Tong T. Cancer statistics,. 1991. CA 1991;41:19-36.
3. Guileyardo JM, Johnson WD, Welsh RA, et al. Prevalence of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst 1980;65:311- 16.
4. Kurihara M, Aoki K, Hisamichi S, eds. Cancer mortality statistics in the world 1950-1985. Nagoya, Japan: University of Nagoya Press, 1989.
5. Spring-Mills E, Krall A. Functional anatomy of the prostate. In: Hafez ESE, Spring-Mills E, eds. Prostatic carcinoma: biology and diagnosis. Hingham, MA: Martinus Nijhoff Publishers, 1981:5-12.
6. Mostofi FK, Davis CJ Jr. Male reproductive system and prostate. In: Kissane JM, ed. Anderson’s pathology. 9th ed. St. Louis, MO: The CV Mosby Company, 1990:871-929.
7. Cotran RS, Kumar V, Robbins SL. Robbins’ pathologic basis of disease. 4th ed. Philadelphia, PA: WB Saunders Company, 1989:1099-1126.
8. American Cancer Society. Cancer facts and figures—1989. New York: American Cancer Society, 1989:12.
9. Halpert B, Sheehan E, Schmalherst WR, et al. A survey of 5,000 autopsies. Cancer 1963;16:737- 42.
10. Karube K. Study of latent carcinoma of the prostate in the Japanese based on necropsy material. Tohoku J Exp Med 1961;74:265-85.
11. Franks GM. Latent carcinoma of the prostate. J Pathol 1954;68:603-16.
12. Yatani R, Chigusa I, Akazaki K, et al. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982;29:611-16.
13. Akazaki K, Stemmerann GN. Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii. J Natl Cancer Inst 1973;50:1137-44.
14. Breslow N, Chan CW, Dhom G, et al. Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 1977;20:680-8.
15. Severson RK, Nomura AMY, Grove JS, et al. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989;49:1857-60.
16. Beckner M, Berg JW, Franz LW. The contribution of subclinical cancer to Denver’s high prostatic cancer incidence rate. J Chronic Dis 1985;38:225-31.
17. Percy C, Van Holten V, Muir C, eds. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization, 1990.
18. National Board of Health and Welfare. The cancer registry: cancer incidence in Sweden 1981. Stockholm, Sweden: Social Styrelsen, 1984.
19. Zaridze DG, Boyle P, Smans M. International trends in prostatic cancer. Int J Cancer 1984; 33:223-30.
20. Hermanek P, Sobin LH, eds. TNM classification of malignant tumors. 4th ed. New York: SpringerVerlag New York, Inc, 1987.
21. American Joint Committee on Cancer. Manual for staging of cancer. 3rd ed. Philadelphia, PA: JB Lippincott Company, 1988.
22. Johansson J-E, Adami H-O, Andersson S-O, et al. Natural history of localised prostatic cancer. Lancet 1989;1:799-803.
23. McNeal JE, Bostwick DG, Kindrachuk RA, et al. Patterns of progression in prostate cancer. Lancet 1986;1:60-3.
24. Muir C, Waterhouse J, Mack T, et al, eds. Cancer incidence in five continents. Vol 5. Lyon, France: International Agency for Research on Cancer, 1987. (IARC scientific publication no. 88).
25. Staszewski J, Haenszel W. Cancer mortality among the Polish-bom in the United States. J Natl Cancer Inst 1965;35:291-7.
26. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:43-68.
27. Kolonel LN, Hinds MW, Hankin JH. Cancer patterns among migrant and native-born Japanese in Hawaii in relation to smoking, drinking, and dietary habits. In: Gelboin HV, MacMahon B, Matsushima T, et al, eds. Genetic and environmental factors in experimental and human cancer: proceedings of the 10th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 1979. Tokyo: Japan Scientific Societies Press, 1980:307-40.
28. Heilbrun LK, Nomura A, Stemmermann GN. The effects of nonresponse in a prospective study of cancer: 15-year follow up. Int J Epidemiol 1991;20:328-38.
29. Enstrom JE. Cancer and total mortality among active Mormons. Cancer 1978;42:1943-51.
30. Lyon JL, Klauber MR, Gardner JW, et al. Cancer incidence in Mormons and non-Mormons in Utah, 1966-1970. N Engl J Med 1976,294:12933.
31. Phillips RL. Role of life-style and dietary habits in risk of cancer among Seventh-day Adventists. Cancer Res 1975;35:3513-22.
32. Parkin DM, Cancer occurrence in developing countries. Lyon, France: International Agency for Research on Cancer, 1986. (IARC scientific publication no. 75).
33. Waterhouse J, Muir C, Correa P, et al, eds. Cancer incidence in five continents. Vol 3. Lyon, France: International Agency for Research on Cancer, 1976. (IARC scientific publication no. 15).
34. Hamilton PJS, Persand V. Cancer among blacks in the West Indies. In: Mettlin C, Murphy GP, eds. Cancer among black populations. New York: Alan R Liss Inc, 1981:1-15.
35. Ross RK, Shimizu H, Paganini-Hill A, et al. Case- control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 1987;78:869-74.
36. Ahluwalia B, Jackson MA, Jones GW, et al. Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations. Cancer 1981;48:2267-73.
37. Hill P, Wynder EL, Garbaczewski L, et al. Effect of diet on plasma and urinary hormones in South African black men with prostatic cancer. Cancer Res 1982;42:3864-9.
38. Heshmat MY, Kaui L, Kovi J, et al. Nutrition and prostate cancer: a case-control study. Prostate 1985;6:7-17.
39. Ogunlewe JO, Osegbe DN. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 1989;63:1388-92.
40. Potosky AL, Kessler L, Gridley G, et al. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst 1990;82:1624-8.
41. Brendler H, Benign prostatic hyperplasia: natural history. In: Grayhack JT, Wilson JD, Scherbenske MJ, eds. Benign prostatic hyperplasia: a workshop. Washington, DC: US GPO, 1976:101-3. (DHEW publication no. (NIH) 76-1113).
42. Brendler H, Benign hyperplasia and cancer of the prostate. (Editorial). BMJ 1975;1:2-3.
43. Armenian HK, Lilienfeld AM, Diamond EL, et al. Relation between benign prostatic hyperplasia and cancer of the prostate. Lancet 1974;2:115-17.
44. Greenwald P, Kirmss V, Polan AK, et al. Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 1974;53:335-40.
45. Franks LM. Benign prostatic hyperplasia. (Letter). Lancet 1974;2:293.
46. Williams RD, Blackard CE. Benign prostatic hyperplasia and cancer of the prostate. (Letter). Lancet 1974;2:1265.
47. Higgins ITT. The epidemiology of cancer of the prostate. J Chronic Dis 1975;28:343-8.
48. Gordon GG, Olivo J, Rafii F, et al. Conversion of androgen to estrogen in cirrhosis of the liver. J Clin Endocrinol Metab 1975;40:1018-26.
49. Anderson KE, Kappas A. Hormones and liver function. In: Schiff L, Schiff ER, eds. Diseases of the liver. Philadelphia, PA: JB Lippincott Company, 1982:167-236.
50. Chopra IJ, Tulchinsky D, Green way FL. Estrogen-androgen imbalance in hepatic cirrhosis. Ann Intern Med 1973;79:198-203.
51. Glantz GM. Cirrhosis and carcinoma of the prostate gland. J Urol 1964;91:291-3.
52. Robson MC. Cirrhosis and prostatic neoplasms. Geriatrics 1966;21:150-4.
53. Wynder EL, Mabuchi K, Whitmore WF Jr. Epidemiology of cancer of the prostate. Cancer 1971;28:344-60.
54. Naik VK, Jochi UM, Sheth AR. Long-term effects of vasectomy on prostatic function in men. J Reprod Fertil 1980;58:289-93.
55. Kinson GA, Layberry RA. Long-term endocrine responses to vasectomy in the adult rat. Contraception 1975;11:143-50.
56. Purvis K, Saksena SK, Cekan Z, et al. Endocrine effects of vasectomy. Clin Endocrinol 1976;5:263- 72.
57. Henderson BE, Ross RK, Pike MC, et al. Endogenous hormones as a major factor in human cancer. Cancer Res 1982;42:3232-9.
58. Ross RK, Paganini-Hill A, Henderson BE. The etiology of prostate cancer: What does the epidemiology suggest? Prostate 1983;4:333-44.
59. Honda GD, Bernstein L, Ross RK, et al. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer 1988;57:326-31.
60. Rosenberg L, Palmer Jr., Zauber AG, et al. Vasectomy and the risk of prostate cancer. Am J Epidemiol 1990;132:1051-5.
61. Mettlin C, Natarajan N, Huben R. Vasectomy and prostate cancer risk. Am J Epidemiol 1990; 132:1056-61.
62. Guess HA. Invited commentary: vasectomy and prostate cancer. Am J Epidemiol 1990; 132:10625.
63. Sidney S. Vasectomy and the risk of prostatic cancer and benign prostatic hypertrophy. J Urol 1987;138:795-7.
64. Krain LS. Some epidemiologic variables in prostatic carcinoma in California. Prev Med 1974; 3:154-9.
65. Steel R, Lees REM, Kraus AS, et al. Sexual factors in the epidemiology of cancer of the prostate. J Chronic Dis 1971;24:29-37.
66. Kolonel LN, Yoshizawa CN, Han kin JH. Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol 1988;127:999-1012.
67. Steinberg GD, Carter BS, Beaty TH, et al. Family history and the risk of prostate cancer. Prostate 1990;17:337-47.
68. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960; 13:73944.
69. Meikle AW, Stanish WM. Familial prostatic cancer risk and low testosterone. J Clin Endocrinol Metab 1982;54:1104-8.
70. Cannon L, Bishop DT, Skolnick M, et al. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1982;1:47-69.
71. Kolonel LN, Hankin JH, Nomura AMY. Multiethnic studies of diet, nutrition, and cancer in Hawaii. In: Hayashi Y, Nagao M, Sugimura T, et al, eds. Diet, nutrition, and cancer: proceedings of the 16th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 1985. Tokyo: Japan Scientific Societies Press, 1986:29-40.
72. Carter BS, Epstein JI, Isaacs WB. Expressions of ras gene mutations in human prostate cancer. Cancer Res 1990;50:6830-2.
73. Viola MV, Fromowitz F, Oravez S, et al. Expressions of ras oncogene p21 in prostate cancer. N Engl J Med 1986;314:133-7.
74. Schuman LM, Mandel J, Blackard C, et al. Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat Rep I977;61:181-6.
75. Armenian HK, Lilienfeld AM, Diamond EL, et al. Epidemiologic characteristics of patients with prostatic neoplasms. Am J Epidemiol 1975; 102:47-54.
76. Ross RK, Deapen DM, Casagrande JT, et al. A cohort study of mortality from cancer of the prostate in Catholic priests. Br J Cancer 1981;43:233- 5.
77. Newill VA. Distribution of cancer mortality among ethnic subgroups of the white population of New York City, 1953-58. J Natl Cancer Inst 1961;26:405-17.
78. Apt A. Circumcision and prostatic cancer. Acta Med Scand 1965;178:493-504.
79. Lilienfeld AM, Graham S. Validity of determining circumcision status by questionnaire as related to epidemiological studies of cancer of the cervix. J Natl Cancer Inst 1958;21:713-20.
80. Rotkin ID. Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat Rep 1977;61:173-80.
81. Zeigel RF, Arya SK, Horoszewicz JS, et al. A status report: human prostatic carcinoma, with emphasis on potential for viral etiology. Oncology 1977;34:29-44.
82. Baker LH, Mebust WK, Chin TDY, et al. The relationship of herpesvirus to carcinoma of the prostate. J Urol 1981;125:370-4.
83. Herbert JT, Birkhoff JD, Feorino PM, et al. Herpes simplex virus type 2 and cancer of the prostate. J Urol 1976;116:611-12.
84. Sanford EJ, Geder L, Laychock A, et al. Evidence for the association of cytomegalovirus with carcinoma of the prostate. J Urol 1977;118:789-92.
85. Eizuru Y, Hyman RW, Nahihas WA, et al. Herpesvirus RNA in human urogenital tumors (41740). Proc Soc Exp Biol Med 1983; 174:296301.
86. Talamini R, La Vecchia C, Decarli A, et al. Nutrition, social factors, and prostatic cancer in a Northern Italian population. Br J Cancer 1986; 53:817-21.
87. Graham S, Haughey B, Marshall J, et al. Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst 1983;70:687-92.
88. Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 1984;120:244-50.
89. Garfinkel L. Overweight and mortality. Cancer 1986;58:1826-9.
90. Whittemore AS, Paffenbarger RS Jr., Anderson K, et al. Early precursors of site-specific cancers in college men and women. J Natl Cancer Inst 1985;74:43-51.
91. Greenwald P, Damon A, Kirmss V, et al. Physical and demographic features of men before developing cancer of the prostate. J Natl Cancer Inst 1974;53:341-6.
92. Gam SM, Leonard WR, Hawthorne VM. Three limitations of the body mass index. Am J Clin Nutr 1986;44:996-7.
93. Severson RK, Grove JS, Nomura AMY, et al. Body mass and prostatic cancer a prospective study. BMJ 1988;297:713-15.
94. Henderson BE. Summary report of the Sixth Symposium on Cancer Registries and Epidemiology in the Pacific Basin. J Natl Cancer Inst 1990;82:1186-90.
95. Lukaski HC. Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 1987;46:537-56.
96. Wilson JD. Recent studies on the mechanism of action of testosterone. N Engl J Med 1972;287: 1284-91.
97. Perez CA, Fair WR, Ihde DC. Carcinoma of the prostate. In: DeVita VT, Heilman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia, PA: JB Lippincott Company, 1989:1023-58.
98. Griffiths K, Eaton CL, Davies P. Prostatic cancer: aetiology and endocrinology. Horm Res 1989; 32(suppl 1):38-43.
99. Coffey DS. Androgen action and the sex accessory tissues. In: Knobil E, Neill JD, Ewing LL, eds. The physiology of reproduction. New York: Raven Press, 1988:1081-1118.
100. Ghanadian R, Puah CM, O’Donoghue EPN. Serum testosterone and dihydrotestosterone in carcinoma of the prostate. Br J Cancer 1979;39: 696-9.
101. Meikle AW, Smith JA, West DW. Familial factors affecting prostatic cancer risk and plasma sexsteroid levels. Prostate 1985;6:121-8.
102. Zumoff B, Levin J, Strain GW, et al. Abnormal levels of plasma hormones in men with prostate cancer: evidence toward a “two-disease” theory. Prostate 1982;3:579-88.
103. Hammond GL, Kontturi M, Vihko P, et al. Serum steroids in normal males and patients with prostatic diseases. Clin Endocrinol 1978;9:113-21.
104. Nomura A, Heilbrun LK, Stemmermann GN, et al. Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res 1988;48:3515-17.
105. Barrett-Connor E, Garland C, McPhillips JB, et al. A prospective, population-based study of an- drostenedione, estrogens, and prostatic cancer. Cancer Res 1990;50:169-73.
106. Wynder EL, Laakso K, Sotarauta M, et al. Metabolic epidemiology of prostatic cancer. Prostate 1984;5:47-53.
107. de Lacerda L, Kowarski A, Johanson AJ, et al. Integrated concentration and circadian variation of plasma testosterone in normal men. J Clin Endocrinol Metab 1973;37:366-71.
108. Robinson MRG, Thomas RS. Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma. BMJ 1971;4:391-4.
109. Cumming DC, Quigley ME, Yen SSC. Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab 1983; 57:671-3.
110. Habib FK, Lee IR, Stitch SR, et al. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate. J Endocrinol 1976;71:99-107.
111. Hirayama T. Changing patterns of cancer in Japan with special reference to the decrease in stomach cancer mortality. In: Hiatt HH, Watson JD, Winsten JA, eds. Origins of human cancer. Book A. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1977:55-75.
112. Berg JW. Can nutrition explain the pattern of international epidemiology of hormone-dependent- cancers? Cancer Res 1975;35:3345-50.
113. Howell MA. Factor analysis of international cancer mortality data and per capita food consumption. Br J Cancer 1974;29:328-36.
114. Blair A, Fraumeni JF. Geographic patterns of prostate cancer in the United States. J Natl Cancer Inst 1978;61:1379-84.
115. Kolonel LN, Hankin JH, Lee J, et al. Nutrient intakes in relation to cancer incidence in Hawaii. Br J Cancer 1981;44:332-9.
116. Schuman LM, Mandel JS, Radke A, et al. Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul, Minnesota, case- control study, 1976-1979. In: Magnus K, ed. Trends in cancer incidence: causes and practical implications. Washington, DC: Hemisphere Publishing Corporation, 1982:345-54.
117. Mettlin C, Selenskas S, Natarajan N, et al. Beta- carotene and animal fats and their relationship to prostate cancer risk. Cancer 1989;64:605-12.
118. West DW, Slattery ML, Robison LM, et al. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special reference to aggressive tumors. Cancer Causes and Control 1991;2:85-94.
119. Slattery ML, Schumacher MC, West DW, et al. Food consumption trends between adolescent and adult years and subsequent risk of prostate cancer. Am J Clin Nutr 1990;52:752-7.
120. Ohno Y, Yoshida O, Oishi K, et al. Dietary beta- carotene and cancer of the prostate: a case-control study in Kyoto, Japan. Cancer Res 1988;48: 1331-6.
121. Mills PK, Beeson WL, Phillips RL, et al. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989;64:598-604.
122. Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. NCI Monogr 1979;53:149-55.
123. Hsing AW, McLaughlin JK, Schuman LM, et al. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran brotherhood cohort study. Cancer Res 1990;50:6836-40.
124. Rose DP. The biochemical epidemiology of prostatic carcinoma. In: Ip C, Birt DF, Rogers AE, et al, eds. Dietary fat and cancer. New York: Alan R Liss, Inc, 1986:43-68.
125. National Research Council, Committee on Diet and Health. Diet and health: implications for reducing chronic disease risk. Washington, DC: National Academy Press, National Academy of Sciences, 1989:314-16.
126. Hill P, Wynder EL, Garbaczewski L, et al. Diet and urinary steroids in black and white North American men and black South African men. Cancer Res 1979;39:5101-5.
127. Middleton B, Byers T, Marshall J, et al. Dietary vitamin A and cancer: a multisite case-control study. Nutr Cancer 1986;8:107-16.
128. Kolonel LN, Hankin JH, Yoshizawa CN. Vitamin A and prostate cancer in elderly men: enhancement of risk. Cancer Res 1987;47:2982-5.
129. Le Marchand L, Hankin JH, Kolonel LN, et al. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: a reevaluation of the effect of dietary beta-carotene. Am J Epidemiol 1991;133:215-19.
130. Hirayama T. A large scale cohort study on cancer risks by diet—with special reference to the risk reducing effects of green-yellow vegetable consumption. In: Hayashi Y, Nagao M, Sugimura T, et al, eds. Diet, nutrition, and cancer: proceedings of the 16th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 1985. Tokyo: Japan Scientific Societies Press,1986:41-53.
131. Paganini-Hill A, Chao A, Ross RK, et al. Vitamin A, beta-carotene, and the risk of cancer: a prospective study. J Natl Cancer Inst 1987;79:443-8.
132. Hayes RB, Bogdanovicz JFAT, Schroeder FH, et al. Serum retinol and prostate cancer. Cancer 1988;62:2021-6.
133. Reichman ME, Hayes RB, Ziegler RG, et al. Serum vitamin A and subsequent development of prostate cancer in the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cancer Res 1990;50:2311-15.
134. Khachik F, Beecher GR, Lusby WR. Separation, identification, and quantification of the major carotenoids in extracts of apricots, peaches, cantaloupe, and pink grapefruit by liquid chromatography. J Agric Food Chem 1989;37:1465-73.
135. Kolonel LN, Winkelstein W Jr. Cadmium and prostatic carcinoma. Lancet 1977;2:566-7.
136. Abd Elghany N, Schumacher MC, Slattery ML, et al. Occupation, cadmium exposure, and prostate cancer. Epidemiology 1990;1:107-15.
137. Heilbrun LK, Nomura A, Stemmermann GN. Black tea consumption and cancer risk: a prospective study. Br J Cancer 1986;54:677-83.
138. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990; 10:1307-11.
139. Mandel JS, Schuman LM. Epidemiology of cancer of the prostate. In: Lilienfeld AM, ed. Reviews in cancer epidemiology. Vol 1. New York: Elsevier/North-Holland Publishing Company, 1980:1-83.
140. Bosland MC. The etiopathogenesis of prostatic cancer with special reference to environmental factors. Adv Cancer Res 1988;51:1-106.
141. Bosland MC. Cadmium, nickel, and some epoxides, miscellaneous industrial chemicals and general considerations on volatile anaesthetics. IARC Monogr Eval Carcinog Risk Chem Man 1976; 11:53-64.
142. Potts CL. Cadmium proteinuria: the health of battery workers exposed to cadmium oxide dust. Ann Occup Hyg 1965;8:55-61.
143. Kipling MD, Waterhouse JAH. Cadmium and prostatic carcinoma. Lancet 1967;1:730-1.
144. Armstrong BG, Kazantzis G. The mortality of cadmium workers. Lancet 1983;1:1425-7.
145. Soraham T, Waterhouse JAH. Cancer of prostate among nickel-cadmium battery workers. (Letter). Lancet 1985;1:459.
146. Kjellstrom T, Friberg L, Rahnster B. Mortality and cancer morbidity among cadmium-exposed workers. Environ Health Perspect 1979;29:199- 204.
147. Lemen RA, Lee JS, Wagoner JK, et al. Cancer mortality among cadmium production workers. Ann N Y Acad Sci 1976;271:273-9.
148. Thun MJ, Schnorr TM, Smith AB, et al. Mortality among a cohort of U.S. cadmium production workers: an update. J Natl Cancer Inst 1985;74: 325-33.
149. Feustel A, Wennrich R, Steiniger D, et al. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibro- myomatosis (BPH). Urol Res 1982;10:301-3.
150. Hambidge KM, Casey CE, Krebs NF. Zinc. In: Mertz W, Underwood EJ, eds. Trace elements in human and animal nutrition. Vol 2. 5th ed. Orlando, FL: Academic Press, Inc, 1986:1-137.
151. Haddow A, Roe FJC, Dukes CE, et al. Cadmium neoplasia: sarcomata at the site of injection of cadmium sulphate in rats and mice. Br J Cancer 1964;18:667-73.
152. Roe FJC, Dukes CE, Cameron KM, et al. Cadmium neoplasia: testicular atrophy and Leydig cell hyperplasia and neoplasia in rats and mice following the subcutaneous injection of cadmium salts. Br J Cancer 1964;18:674-81.
153. Gunn SA, Gould TC, Anderson WAD. Specific response of mesenchymal tissue in carcinogenesis by cadmium. Arch Pathol 1967;83:493-9.
154. McMichael AJ, Spirtas R, Kupper LL. An epidemiologic study of mortality within a cohort of rubber workers, 1964-72. J Occup Med 1974;16: 458-64.
155. Williams RR, Stegens NL, Goldsmith JR. Associations of cancer site and type of occupation and industry from the Third National Cancer Survey Interview. J Natl Cancer Inst 1977;59:1147-85.
156. Delzell E, Monson RR. Mortality among rubber workers. III. Cause-specific mortality, 1940-1978. J Occup Med 1981;23:677-84.
157. Monson RR, Nakano KK. Mortality among rubber workers. I. White male union employees in Akron, Ohio. Am J Epidemiol 1976;103:284-96.
158. McMichael AJ, Spirtas R, Gamble JF, et al. Mortality among rubber workers: relationship to specific jobs. J Occup Med 1976;18:178-85.
159. Goldsmith DF, Smith AH, McMichael AJ. A case- control study of prostate cancer within a cohort of rubber and tire workers. J Occup Med 1980; 22:533-41.
160. Delzell E, Monson RR., Mortality among rubber workers. V. Processing workers. J Occup Med 1982;24:539-45.
161. Wilcosky TC, Checkoway H, Marshall EG, et al. Cancer mortality and solvent exposures in the rubber industry. Am Ind Hyg Assoc J 1984;45: 809-11.
162. The rubber industry. IARC Monogr Eval Carcinog Risk Chem Man 1982;28:1-486.
163. Ernster VL, Selvin S, Brown SM, et al. Occupation and prostatic cancer: a review and retrospective analysis based on death certificates in two California counties. J Occup Med 1979;21:175-83.
164. Delzell E, Grufferman S. Mortality among white and nonwhite farmers in North Carolina, 1976- 1978. Am J Epidemiol 1985;121:391-402.
165. Burmeister LP, Everett GD, Van Lier SF, et al. Selected cancer mortality and farm practices in Iowa. Am J Epidemiol 1983; 118:72-7.
166. Brownson RC, Chang JC, Davis JR, et al. Occupational risk of prostate cancer: a cancer registry- based study. J Occup Med 1988;30:523-6.
167. Pearce NE, Sheppard RA, Fraser J. Case-control study of occupation and cancer of the prostate in New Zealand. J Epidemiol Community Health 1987;41:130-2.
168. Pearce NE, Howard JK. Occupation, social class, and male cancer mortality in New Zealand, 197478. Int J Epidemiol 1986;15:456-62.
169. Carstensen J, Pershagen G, Eklund G. Mortality in relation to cigarette and pipe smoking: 16 years’ observation of 25,000 Swedish men. J Epidemiol Community Health 1987;41:166-72.
170. Doll R, Peto R. Mortality in relation to smoking: 20 years’ observation on male British doctors. BMJ 1976;2:1525-36.
171. Hammond EC. Smoking in relation to the death rates of one million men and women. NCI Monogr 1966;19:127-204.
172. Weir JM, Dunn JE. Smoking and mortality: a prospective study. Cancer 1970;25:105-12.
173. Kahn HA. The Dorn Study of smoking and mortality among U.S. veterans: report of eight and one-half years of observation. NCI Monogr 1966; 19:1-125.
174. Dai WS, Gutai JP, Kuller LH, et al. Cigarette smoking and serum sex hormones in men. Am J Epidemiol 1988;128:796-805.
175. Sundby P. Alcoholism and mortality. Oslo, Norway: Universitetsforlaget, 1967. (National Institute for Alcohol Research publication no. 6).
176. Schmidt W, DeLint J. Causes of death of alcoholics. Q J Stud Alcohol 1972;33:171-85.
177. Pell S, D’Alonzo CA. A five-year mortality study of alcoholics. J Occup Med 1973;15:120-5.
178. Monson RR, Lyon JC. Proportional mortality among alcoholics. Cancer 1975;36:1077-9.
179. Badr FM, Bartke A. Effect of ethyl alcohol on plasma testosterone level in mice. Steroids 1974; 23:921-8.
180. Adlercreutz H. Hepatic metabolism of estrogens in health and disease. N Engl J Med 1974;290: 1081-3.
181. Ylikahri R, Huttunen M, Harkonen M, et al. Low plasma testosterone values in men during hangover. J Steroid Biochem 1974;5:655-88.
182. Gordon GG, Olivo J, Rafii F, et al. Conversion of androgens to estrogens in cirrhosis of the liver. J Clin Endocrinol Metab 1975;40:1018-26.
183. Rubin E, Lieber CS, Altman K, et al. Prolonged ethanol consumption increases testosterone metabolism in the liver. Science 1976;191:563-4.
184. Smith PG, Doll R. Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. BMJ 1982;284:449-60.
185. Bean MA, Yatani R, Liu PI, et al. Prostate carcinoma at autopsy in Hiroshima and Nagasaki Japanese. Cancer 1973;32:498-506.
186. Angevine DM, Jablon S. Late radiation effects of neoplasia and other diseases in Japan. Ann N Y Acad Sci 1964;114:823-31.
187. Watanabe S. Neoplasms among atomic bomb survivors in Japan. In: Cancer epidemiology: environmental factors. Proceedings of the 11th International Cancer Congress, Florence, Italy, October 20-26, 1974. Vol 3. Amsterdam, The Netherlands: Excerpta Medica, 1974.
188. Wakabayashi T, Kato H, Ikeda T, et al. Studies of the mortality of A-bomb survivors, report 7. Part III. Incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki. Radiat Res 1983; 93:112-46.
189. Beral V, Inskip H, Fraser P, et al. Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. BMJ 1985;291:440-7.
190. Smith PG, Douglas AJ. Mortality of workers at the Sellafield plant of British nuclear fuels. BMJ 1986;293:845-54.
191. Wilkinson GS, Tietjen GL, Wiggs LD, et al. Mortality among plutonium and other radiation workers at a plutonium weapons facility. Am J Epidemiol 1987;125:231-50.
192. Rivenson A, Silverman J. The prostatic carcinoma in laboratory animals: a bibliographic survey from 1900 to 1977. Invest Urol 1979; 16:46872.
193. Ward JM, Reznik G, Stinson SF, et al. Histogenesis and morphology of naturally occurring prostatic carcinoma in the ACI/segHapBR rat. Lab Invest 1980;43:517-22.
194. Prejean JD, Peckham JC, Casey AE, et al. Spontaneous tumors in Sprague-Dawley rats and Swiss mice. Cancer Res 1973;33:2768-73.
195. Pollard M. Spontaneous prostate adenocarcinomas in aged germfree Wistar rats. J Natl Cancer Inst 1973;51:1235-41.
196. Fortner JG. The influence of castration on spontaneous tumorigenesis in the Syrian (Golden) hamster. Cancer Res 1961;21:1491-8.
197. Nielsen SW. Canine and feline neoplasia. In: Melby EC Jr, ed. Handbook of laboratory animal science. Vol 3. Boca Raton, FL: CRC Press, 1976:892-932.
198. Leav I, Ling GH. Adenocarcinoma of the canine prostate. Cancer 1968;22:1329-45.
199. Brendler H. Experimental prostatic cancer: background of the problem. NCI Monogr 1963; 12: 343-9.
200. Goodpasture EW. An anatomical study of senescence in dogs with especial reference to the relation of cellular changes of age to tumors. J Med Res 1918;38:127-89.
201. Engle ET, Stout AP. Spontaneous primary carcinoma of the prostate in a monkey (Macaca mulatto). Am J Cancer 1940;39:334-7.
202. Mirand EA, Staubitz WJ. Prostatic neoplasms of the Wistar rat induced with 20-methylcholan- threne. Proc Soc Exp Biol Med 1956;93:457-62.
203. Katayama S, Fiala E, Reddy BS, et al. Prostate adenocarcinoma in rats: induction by 3,2'- dimethyl-4-aminobiphenyl. J Natl Cancer Inst 1982;68:867-73.
204. Hirose F, Takizawa S, Watanabe H, et al. Development of adenocarcinoma of the prostate in ICR mice locally irradiated with X-rays. Gann 1976;67:407-11.
205. Brown CE, Warren S. Carcinoma of the prostate in irradiated parabiotic rats. Cancer Res 1978; 38:159-62.
206. Watanabe N, Ito A, Hirose F. Environmental carcinogenesis in the digestive genitourinary tract. In: Upton AC, Albert RE, Bums FJ, et al, eds. Radiation carcinogenesis. New York: Elsevier Science Publishing Company, 1986:233-44.
207. Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977; 37:1929-33.
208. Pollard M, Luckert PH, Schmidt MA. Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone. Prostate 1982;4:563-8.
209. Bosland MC, Prinsen MK, Kroes R. Adenocarcinomas of the prostate induced by N-nitroso-N- methylurea in rats pretreated with cyproterone acetate and testosterone. Cancer Lett 1982; 18:69-78.
210. Pollard M, Luckert PH. Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone. J Natl Cancer Inst 1986;77:583-7.
211. Pour PM, Stepan K. Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine. Cancer Res 1987;47:5699-706.
212. Pollard M, Luckert PH. Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 1986;32:223-7.